Skip to content
OpenCapital
Get started

BioSig Technologies, Inc. STEX Cash & Equivalents

Cash & Equivalents at other companies

Tradeweb Markets Inc. logo
Tradeweb Markets Inc.TW
$1.94B+48.2%
Bit Digital logo
Bit DigitalBTBT
$83.85M+36.8%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$3.35M-42.2%
DigitalBridge Group logo
DigitalBridge GroupDBRG
$411.33M+17.6%
StoneX Group Inc. logo
StoneX Group Inc.SNEX
$12.79B+114%
TEC
Bio-TechneTECH
$209.82M+49.2%

Segments

By geography

See full
CA$4.91M—
US$1.95M—

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%—
Debt / equity0×—
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Cash.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s cash & equivalents?
BioSig Technologies, Inc. (STEX) reported cash & equivalents of $6.86M in Q1 2026.
How has BioSig Technologies, Inc.'s cash & equivalents changed year-over-year?
BioSig Technologies, Inc.'s cash & equivalents increased by 84.0% year-over-year, from $3.73M to $6.86M.
What is the long-term trend for BioSig Technologies, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s cash & equivalents has grown at a -6.4% compound annual growth rate (CAGR), from $28.27M to $20.32M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.